Navigation Links
Leading virologists join together to tackle viruses, leukemia and neurologic disorders
Date:6/17/2014

The Global Virus Network (GVN) announced today the launch of a Task Force on HTLV, Human T-Lymphotropic Virus (HTLV), the world's first known human retrovirus and only known leukemia-causing virus. Experts from 11 countries*, led by Dr. Robert Gallo, GVN co-founder and scientific director and director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine, Dr. Luc Willems (Research Director, National Fund for Scientific Research at University of Lige) and Dr. Hideki Hasegawa (Director, Department of Pathology, National Institute of Infectious Diseases, Japan) are leading the Task Force, which met for the first time last month.

"There are no effective vaccines against HTLV, no antiviral drugs to treat infections, and though there are diagnostic tests for the virus none yet can predict which infected person gets disease," said Dr. Gallo who pioneered the field of human retrovirology with his groundbreaking discoveries of HTLV- 1 in 1980 and HTLV-2 in 1982. "This Task Force is critical as the global community works together to address a problem which in many countries is under-recognized and under-appreciated," he continued.

More than 20 million people worldwide are infected with the virus, of which up to 10% will develop debilitating and sometimes deadly disease. HTLV causes an adult T-cell leukemia/ lymphoma (ATL), HTLV-associated myelopathy (HAM), spastic paraparesis, and other rare illnesses. Signs and symptoms of HTLV infection include motor and sensory changes in the extremities, inflammation in the spinal cord, a spastic gait in combination with weakness of the lower limbs, cognitive impairment, bladder dysfunction and bladder cancer. HTLV, similar to the human immunodeficiency virus (HIV), also co-discovered by Dr. Gallo as the cause of AIDS, is transmitted through sexual contact, from mother to child via breastfeeding, and through exposure to contaminated blood.

"This task force is to set the common goal among the scientists around the world to accelerate the research in order to overcome HTLV and related diseases," said Dr. Hideki Hasegawa of Japan's National Institute of Infectious Diseases.

The mission of the HTLV Task Force is to speed the pathway to discovery of drugs that will stop virus transmission or progression from infection to disease, in addition to educating the public about the nature of these viruses, the diseases they cause, and how to prevent their spread.

Dr. Sharon Hrynkow, President of GVN, concluded, "We are excited to be able to bring together leading experts to mobilize more research and more attention to HTLV by governments in order to help communities most affected by this insidious virus."


'/>"/>

Contact: Nora Grannell
ngrannell@gvn.org
410-706-1966
Global Virus Network
Source:Eurekalert

Related biology news :

1. Leading cfaed scientists organize international workshop about DNA-based microchips
2. Synaptics to Showcase Industry-Leading Human Interface Solutions At 2014 Consumer Electronics Show
3. Uncovering first molecular missteps that drive neurons in pathway leading to Alzheimers disease
4. IU-designed probe opens new path for drug development against leading STD
5. First International Bioenergy Conference brings together world-leading experts
6. Genetic signature identified for RSV, the leading cause of infant hospitalizations worldwide
7. Leading Pharma Company Selects Clinilabs to Conduct a Phase 1 Study of an Investigational Type 2 Diabetes Medication
8. RIKEN and leading Indian institutions launch Joint Research Centers
9. Marvin Test Solutions Featured at AUTOTESTCON 2013 with Leading Armament Experts and Test Systems
10. FPC Awarded new Smartphone DW From Existing Prominent Asian OEM Customer for Launch With Leading US Operator
11. Join Leading Organizations at Biodetection Technologies 2013 in Alexandria, VA from June 18-19, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Vilnius, Lithuania, announced today that they have entered into a multiyear collaboration to ... provide CRISPR researchers with additional tools for gene editing across all applications. , ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Surgical Wound Market with the addition of its newest module, US Hemostats & ... market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants ...
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... ) has launched Rosalindâ„¢, the first-ever genomics analysis platform specifically designed for ... complexity. Named in honor of pioneering researcher Rosalind Franklin, who made a ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
Breaking Biology Technology: